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Abstract
Objectives To evaluate enhancing synovial thickness upon
contrast-enhanced magnetic resonance imaging (MRI) of the
knee in children unaffected by clinical arthritis compared with
clinically active juvenile idiopathic arthritis (JIA) patients. A
secondary objective was optimization of the scoring method
based on maximizing differences on MRI between these
groups.
Methods Twenty-five children without history of joint com-
plaints nor any clinical signs of joint inflammation were age/
sex-matched with 25 clinically active JIA patients with arthri-
tis of at least one knee. Two trained radiologists, blinded for
clinical status, independently evaluated location and extent of
enhancing synovial thickness with the validated Juvenile
Arthritis MRI Scoring system (JAMRIS) on contrast-
enhanced axial fat-saturated T1-weighted MRI of the knee.
Results Enhancing synovium (≥2 mm) was present in 13
(52 %) unaffected children. Using the total JAMRIS score
for synovial thickening, no significant difference was found
between unaffected children and active JIA patients (p=
0.091). Additional weighting of synovial thickening at the
JIA-specific locations enabled more sensitive discrimination
(p=0.011).
Conclusions Mild synovial thickening is commonly present
in the knee of children unaffected by clinical arthritis. The
infrapatellar and cruciate ligament synovial involvement were
specific for JIA, which—in a revised JAMRIS—increases the
ability to discriminate between JIA and unaffected children.
Key Points
• Synovial inflammation is the primary disease feature in ju-
venile idiopathic arthritis (JIA).
• Appearance of the synovium on contrast-enhanced MRI in
unaffected children is unknown.
• Validation of existing scoring methods requires comparison
between JIA and unaffected children.
• Mild enhancing synovial thickening was detected in half of
the unaffected children.
• Location-weighting for JIA-specific locations increased dis-
criminative value of the scoring methods (p=0.011).
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Juvenile idiopathic arthritis (JIA) is the most common form of
childhood arthritis and is characterized by inflammation of the
synovium. Early and aggressive treatment is warranted for the
prevention of permanent joint damage and the achievement of
inactive disease [1–3]. Magnetic resonance imaging (MRI) is
currently state of the art in JIA, especially in early stage dis-
ease [4]. Additionally, MRI scans of the knee of JIA patients
are easily, reliably and quantitatively assessed by means of the
Juvenile Arthritis MRI Scoring system (JAMRIS), which is a
composite score on four domains (synovial thickening upon
contrast enhancement, bone marrow oedema, cartilage lesions
and bone erosions) [5]. Although the intravenous (IV) admin-
istration of contrast is a disadvantage of MRI in the assess-
ment of disease activity in JIA patients, it is essential for ad-
equate depiction of the synovium as the primary target of
disease [6–8].
After selecting relevant features and reliability studies of
the current scoring method JAMRIS, the next step in the val-
idation is the comparison of JIA and children unaffected by
clinical arthritis [5, 9]. The need for data regarding the appear-
ance of healthy paediatric joints upon MRI was also empha-
sized by the Outcome Measures in Rheumatology Clinical
Trials (OMERACT) Special Interest Group for MRI in JIA
[10], especially because enhancing synovial thickening on
MRI after IV contrast administration was commonly observed
in previous MRI studies in healthy adults [11–13].
Awareness of the appearance of the enhancing synovium in
unaffected children is crucial to differentiate between physio-
logic and pathologic thickness of the synovium. An accurate
distinction between these two may have important implica-
tions for treatment decisions in JIA patients. Currently, the
differentiation between normal synovium and synovial thick-
ening with JAMRIS is made on the basis of a cut-off value for
thickness of pathologically enhancing synovium of 2.0 mm,
as assessed in JIA patients only [5]. However, this cut-off
value is arbitrary as knowledge of the synovial thickness on
MRI in healthy children is lacking. Performing contrast-
enhanced MRI of the knee in healthy children was considered
unethical by our institutional review board. To assess the
appearance of the synovium by MRI in children unaffected
by clinical arthritis, we included patients suspected or diag-
nosed with inflammatory bowel disease (IBD) who underwent
magnetic resonance enterography (MRE) with IV contrast.
Our study design obviously needed precautionary mea-
sures to ensure that the appearance of the synovium mimics
that of the healthy population as well as possible, e.g. with
respect to timing of IV contrast and exclusion of joint com-
plaints. The objectives of this study were (1) to evaluate en-
hancing synovial thickness upon contrast-enhanced MRI of
the knee in children unaffected by clinical arthritis compared
with clinically active JIA patients and (2) to explore the pos-
sibilities to optimize JAMRIS bymaximizing the difference in
synovial thickening between unaffected children and clinical-
ly active JIA patients.
Materials and methods
Children unaffected by clinical arthritis
The cohort of children unaffected by clinical arthritis
consisted of prospectively included children suspected or di-
agnosed with IBD between 8 and 18 years of age, who
underwent MRE with IV contrast between April 2012 and
March 2014. The activity of the underlying IBD was evaluat-
ed with either the Paediatric Crohn’s Disease Activity Index
(PCDAI) or the Paediatric Ulcerative Colitis Activity Index
(PUCAI) [14, 15]. The PCDAI ranges from 0 to 100 points
(with a score of less than 10 considered inactive disease, 10–
30 mild disease and above 30 moderate to severe disease) and
the PUCAI ranges from 0 to 85 points (similar disease activity
cut-off values). Exclusion criteria for this cohort of children
unaffected by clinical arthritis were congenital or genetic joint
abnormalities, a history of trauma in both knees (if only one
knee suffered trauma, the other knee was imaged), and any
arthritic diseases or other chronic conditions affecting the
skeleton. The physical examination was performed by a re-
search fellow trained by an experienced paediatric rheumatol-
ogist (25 years of experience) and by means of the validated
paediatric Gait Arms Legs Spine (pGALS) screening tool
[16]. Both exclusion criteria and physical examination were
used to ensure that the joints of these patients undergoing
MRE were asymptomatic. Medication use and indication for
MRI were registered as well.
The MRI examinations were performed on a 1.5-T MRI
scanner (MAGNETOM Avanto™ 1.5 T MRI, Siemens
Medical Systems). None of the patients received anaesthetics
for their MRI. After the regular MRE with IV contrast injec-
tion (Gadovist, Bayer Schering Pharma, Berlin, Germany,
1.0 mmol gadolinium/mL, dose 0.1 mmol/kg of bodyweight),
a dedicated knee coil was connected. The MRE sequences
after injection of IV contrast were a coronal and axial T1
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VIBE sequence with fat saturation (approximately 4 min to-
gether). An axial T1-weighted sequence with fat saturation of
the right knee was performed (TR 400–750 ms, TE 10 ms;
slice thickness 4 mm; field of view 150×150 mm, matrix
384×384). If the patient suffered recent trauma in the right
knee (and therefore disturbing the healthy appearance), the left
knee was imaged. Time between injection of IV contrast and
start of the MRI sequence of the knee was registered. This
study was approved by the institutional review board and all
participants (and their parents if the patients were younger
than 16 years old) gave written informed consent.
Clinically active JIA patients
JIA patients with clinical arthritis of at least one knee (hence-
forth referred to as ‘clinically active JIA patients’) were de-
rived from our MRI in JIA study database. Patients who con-
secutively visited from April 2012 (start inclusion asymptom-
atic controls) and who underwent an MRI scan of the knee
were age- and sex-matched to the asymptomatic control co-
hort. Clinical characteristics have been prospectively collected
in our MRI in JIA study database. Reported in this study are
the JIA subtype, disease duration (from disease onset until
MRI), medication use and Juvenile Arthritis Disease
Activity Score (JADAS). The JADAS-10 (ranging from 0 to
40) is the sum of the scores of the physician and parent/patient
global assessment of disease activity, reduced 10-active joint
count and a normalized value of erythrocyte sedimentation
rate to a 0–10 scale [17]. All parents of the JIA patients and
JIA patients older than 12 years gave written informed
consent.
The imaging protocol of the MRI of the knee in JIA pa-
tients on the open-bore 1.0-Tscanner (Panorama HFO, Philips
Healthcare) consists of six sequences. For comparison with
the unaffected children, only the axial T1-weighted sequence
with fat saturation after IV contrast was used (Gadovist, Bayer
Schering Pharma, Berlin, Germany, 1.0 mmol gadolinium/
mL, dose 0.1 mmol/kg). Parameters of this sequence (TR,
TE, slice thickness, field of view) were similar to the sequence
performed in the unaffected children.
Image analysis
The synovium on MRI of the knee was evaluated on six well-
defined locations (suprapatellar, patellofemoral, infrapatellar,
cruciate ligaments, medial posterior condyle and lateral pos-
terior condyle) following the validated JAMRIS system for
the knee (Fig. 1) [5]. The thickness of the enhancing synovium
was, if possible, measured at each location and scored follow-
ing the JAMRIS system (0, enhancing synovium less than
2 mm; 1, enhancing synovium from at least 2 to 4 mm; 2,
enhancing synovium at least 4 mm) [5]. The total JAMRIS
score consists of the sum of the scores for enhancing
synovium at all six locations.
The MRI data sets of the knee of both the unaffected chil-
dren and the JIA patients were blinded (for age, gender and
asymptomatic/JIA group) and randomized. Two experienced
readers (radiologists with 6 and 19 years of experience in
musculoskeletal radiology) independently evaluated all im-
ages. Agreement on the incongruent cases (difference between
readers in total JAMRIS score greater than 1) was obtained
afterwards in a consensus reading. If the difference in total
JAMRIS score between the readers was less than 1, the score
of the most experienced reader was adopted.
Possibilities to optimize the JAMRIS score were explored
by means of a concept which was inspired by previous work
on preferred locations for JIA on MRI [18]. The preferred
locations were identified on the basis of a significantly higher
JAMRIS score in the JIA patients compared to the unaffected
children. For these locations we applied a weighting measure;
this simple JAMRIS revision comprised the doubling of the
score for enhancing synovial thickening at the JIA-specific
Fig. 1 The locations at which enhancing synovial thickening on MRI of
the knee is scored according to the Juvenile Arthritis MRI Scoring system
(JAMRIS) [5]. On a sagittal T1-weighted sequence (a) and an axial fat-
saturated T1-weighted sequence (b) of the knee the six locations are
exemplified with different colours: blue suprapatellar, red patellofemoral,
green infrapatellar, yellow cruciate ligaments, purple medial and lateral
posterior condyle
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infrapatellar and/or cruciate ligament locations, meaning that
an additional point was added to the total score when contrast-
enhanced thickening of the synovium (at least 2 mm) was only
present at these two JIA-specific locations [18].
Statistical analysis
Descriptive statistics (mean, standard deviation (SD), percent-
ages) were used to describe baseline characteristics and MRI
findings. Bland–Altman plots were used to assess the agree-
ment between the two readers. Mann–Whitney U test was
used to analyse differences between the groups in total MRI
scores and time between injection of contrast and start of MRI
sequence. The Pearson correlation coefficient was used to
assess the correlation between mean synovial thickness and
the time between injection of contrast and start of MRI se-
quence, because the timing can influence the appearance of
the synovium [19]. All data were analysed using SPSS soft-
ware, version 20 (SPSS, Chicago, IL, USA).
Results
Patient characteristics
Twenty-five children unaffected by clinical arthritis previous-
ly diagnosed with (68 %) or suspected of having (32 %) IBD
underwent MRE (for diagnosis or evaluation of the extent of
the IBD), followed by an additional MRI sequence of the
knee. Clinical arthritis in these children unaffected by JIA
was ruled out through stringent exclusion criteria, question-
naires and simultaneous physical examination at the moment
of imaging. For comparison, 25 age- and sex-matched clini-
cally active JIA patients were included in the study. Baseline
characteristics of both groups are summarized in Table 1.
Overall image analysis
The total JAMRIS scores for synovial thickening of the two
readers corresponded (difference in total score at most 1) in 38
of the 50 MRI data sets. In 25/38 data sets the difference in
total JAMRIS score was 1, so the score of the most senior
reader was adopted. The agreement between the two readers
was very good, as depicted in the Bland–Altman plot in
Supplementary File 1.
Imaging findings
Enhanced thickening (at least 2 mm) of the synovium on at
least one out of six well-defined locations was present upon
MR imaging of the knee in 13/25 (52 %) of the unaffected
children (Fig. 2), compared to 16/25 (64 %) of the active JIA
patients. The maximum total JAMRIS score for synovial
thickening in unaffected children was 3, with no location scor-
ing higher than 1 (i.e. less than 4 mm).
Upon analysis of the total population (including both unaf-
fected children and JIA patients), we found no correlation
between the time (in minutes) between injection of IV contrast
and start of the MRI knee sequence and the mean synovial
thickness per reader (correlation coefficients −0.013 and
−0.140, p=0.378–0.929). Furthermore, when only evaluating
the unaffected children and dividing them into those requiring
less than 10 min and those requiring at least 10 min between
injection of contrast and start of the MRI sequence, no signif-
icant differences were found in the total JAMRIS score for
Table 1 Baseline characteristics of children unaffected by clinical






Female, n (%) 11 (44) 11 (44)
Age at MRI, years 13.5 (±2.5) 13.3 (±2.5)
IV contrast – MRI knee, minutes 10.5 (±2.4) 4.9 (±1.1)*
Immunomodulatory drugsa, n (%) 15 (60) 8 (32)
PCDAI (n=19) 23 (±14) –
PUCAI (n=6) 29 (±28) –
Diagnosis IBDb, n (%)
Crohn’s disease 18 (72.0) –
Ulcerative colitis 4 (16.0) –
No or other disorder 3 (12.0) –
JIA disease duration, months – 34 (±32.7)
JADAS-10 (0–40) – 11 (±6)
Diagnosis JIA, n (%)
Oligo-articular persistent – 4 (16)
Oligo-articular extended – 1 (4)
Poly-articular RF− – 10 (40)
Poly-articular RF+ – 1 (4)
ERA – 8 (32)
Unclassified – 1 (4)
Unless indicated otherwise, values are mean (SD)
ERA enthesitis-related arthritis, IBD inflammatory bowel disease, IV in-
travenous, JADAS Juvenile Arthritis Disease Activity Score, JIA juvenile
idiopathic arthritis, PCDAI Paediatric Crohn’s Disease Activity Index,
PUCAI Paediatric Ulcerative Colitis Activity Index, RF rheumatoid
factor
*p<0.05
a Immunomodulatory drugs in the children unaffected by JIA included
mesalazine (in 4 children), azathioprine (in 7 children, dosed at 2.0–
2.5 mg/kg) and prednisone (in 4 children at 0.8, 1.0 and 5.0 mg/kg,
respectively) for IBD, whereas in JIA the drugs methothrexate (at 10–
15 mg/m2 per week, in 7 patients) and/or anti-tumour necrosis factor
(TNF)-alpha (in 2 patients) were used
b These numbers represent the final diagnosis, not the diagnosis at time of
MRE
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synovitis (p=0.403) or the mean synovial thickness per reader
(p=0.126 and p=0.341).
Also the use of immunomodulatory drugs (i.e. azathioprine
and prednisone) in the unaffected children did not result in a
suppression of the contrast-enhancement of the synovium in
the knee, because no difference in total JAMRIS score of was
found between unaffected children with and those without
taking immunomodulatory drugs (p=0.120).
Being confident about the data quality and ability to com-
pare the imaging data obtained from the different cohorts, we
analysed these data in greater detail. We observed a surpris-
ingly large overlap of the total JAMRIS score between active
JIA patients and children unaffected by clinical arthritis
(Fig. 3), which was reflected by a lack of a significant differ-
ence in the absolute total JAMRIS score as currently used for
synovial thickening (p=0.091). Thirty-six per cent of the ac-
tive JIA patients showed no synovial thickening onMRI (total
JAMRIS score 0).
Although the total JAMRIS scores for synovial thickening
were within the same range, when unaffected children and
active JIA patients were analysed per location, the mean
JAMRIS score was significantly different at two out of six
locations: infrapatellar (p=0.011) and cruciate ligaments (p=
0.007). An example of this typical enhancing thickened
synovium at the infrapatellar and cruciate ligament location
in a JIA patient is given in Fig. 4. To optimize the JAMRIS
score by maximizing the differences between active JIA and
unaffected children, we applied a weighting measure for the
locations with enhancing thickened synovium in JIA cases
only. This revised JAMRIS score with a doubling of the score
for infrapatellar and cruciate ligament locations resulted in
considerably less overlap between active JIA and unaffected
children (Fig. 5) with a significant difference between groups
(p=0.011).
The infrapatellar region was highly specific for JIA as it
was never affected in any of the children without clinical ar-
thritis. Increased signal enhancement at this infrapatellar re-
gion was not mistaken for fat pad oedema due to patellar
maltracking, because this oedema occurs in the superolateral
aspect of the fat pad and the synovial thickening we scored
only occurred in the central part of the infrapatellar region
[20].
Discussion
This study is the first to determine the appearance of the
synovium on contrast-enhancedMRI comparing clinically ac-
tive JIA patients with children unaffected by clinical arthritis.
Enhancing synovium (at least 2 mm) was found to be present
in the majority of unaffected children. Although the total score
for synovial thickening showed a major overlap between ac-
tive JIA patients and unaffected children, there were notice-
able JIA-specific properties of JAMRIS, including a total
score of greater than 3, a score of 2 at any of the six locations
and isolated presence of enhancing thickened synovium at the
infrapatellar region and/or near the cruciate ligaments. A sim-
ple revision of JAMRIS using a certain weighting of these
unique and JIA-specific locations resulted in an improvement
in the possibility to discriminate between active JIA patients
and unaffected children.
To ensure that the presence of enhancing synovium in our
study population is representative for all children unaffected
by JIA, factors possibly contributing to a high incidence of
synovial contrast enhancement were ruled out. The most im-
portant factor with a possible influence on the thickness of
Fig. 2 A 12-year-old boy unaffected by JIA shows presence of enhanc-
ing synovial thickening greater than 2 mm on an axial T1-weighted MR
image of the knee Fig. 3 The total JAMRIS scores for synovial thickening with mean and
standard error of the mean (represented by the black lines) in the
unaffected children (orange) and active JIA patients (blue)
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enhancing synovium on MRI was considered to be the timing
of the administration of IV contrast [19]. As a result of the
necessity to change the body coil after MRE to a dedicated
knee coil, timing was significantly different between the two
groups. This leads to a possible ‘overestimation’ of the syno-
vial thickness in the unaffected children, as the contrast dif-
fuses out of the synovial membrane over time. There is no
consensus on the timing of IV contrast in the literature, but it
is said that the distinction between synovium and effusion can
be reliably made within the first 15 min after administration of
IV contrast [19, 21]. While there was no association between
the time between injection of IV contrast and the MRI se-
quence (in minutes) and the mean synovial thickness per read-
er or total JAMRIS score, this factor was believed not to in-
fluence the interpretation of synovial thickness in our study
population.
The other factor possibly contributing to the high incidence
of enhancing thickened synovium was the patient population
itself. The necessity of an IV contrast agent for adequate vi-
sualization of the synovium on MRI creates a difficult ethical
issue, as the administration of IV contrast and the invasiveness
of an infusion are not desirable in completely healthy children
without any disease manifestation. For the design of this im-
aging study, we hence selected a population of children with-
out joint complaints, with a relatively low disease burden and
already receiving an MRI with IV contrast for regular patient
care. The risk of signs of arthritis on MRI in our paediatric
control group was maximally reduced, having excluded pa-
tients with any joint complaints at any time. These unaffected
were children suspected of having or diagnosed with IBD,
who may hence suffer from an autoimmune inflammatory
disease burden similar to patients with JIA. However, strict
exclusion criteria and thorough physical examination by
means of a validated checklist (pGALS) were undertaken to
avoid any chance of clinical arthritis in these children unaf-
fected by JIA [16]. In large registry studies, the incidence of
clinical arthritis among IBD patients has repeatedly been re-
ported to be very low (less than 4 %) [22, 23].
Considering the aforementioned methodological issues of
little if any relevance for the data analysis, the outcome of the
results needs further discussion. The presence of enhancing
synovial thickening in children unaffected by clinical arthritis
was reminiscent of previous studies in adults that suggested
synovial thickening was present upon MRI of the knee in
adult healthy controls [13, 24]. The finding of minor synovial
thickening (total score less than 3) in the unaffected children
would not cause any problem if the total score with JAMRIS
for synovial thickening in the active JIA patients were signif-
icantly higher. However, the results of our study showed large
overlap in scores between these children unaffected by clinical
arthritis and active JIA patients. This could be explained in
several ways.
First, synovial thickening onMRI may not be present in all
clinically active JIA patients. Our results showed that in 32 %
of the clinically active JIA patients synovial thickening upon
MRI of the knee was found to be absent (JAMRIS score 0).
This discrepancy between clinical findings and imaging re-
sults was reported in several previous studies as well [18,
25, 26]. Ethical issues will prevent us from comparing
biopsy-proven synovial changes in JIA versus control tissue
samples. The lack of this true gold standard for the presence of
synovitis in the paediatric joint would thus impede full clari-
fication of the absence of synovial thickening on MRI in clin-
ically active JIA patients and justifies our current studies in
Fig. 4 An example of the axial T1-weighted MRI sequence of the knee
in a 15-year-old clinically active JIA patient with typical enhancing and
thickened synovium at the cruciate ligament location (thick arrow) and
the infrapatellar location (thin arrow)
Fig. 5 The total revised JAMRIS scores for synovial thickening with
mean and standard error of the mean (represented by the black lines) in
the unaffected children (orange) and active JIA patients (blue). The
revised JAMRIS score comprised a weighting of the isolated presence
of synovial thickening at the infrapatellar and/or cruciate ligament
location
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unaffected children. Additional ongoing follow-up studies in
larger JIA study samples are needed to clarify whether these
MRI-negative yet clinically active JIA patients are more likely
to represent a subgroup with a different type of joint
pathology.
Secondly, the overlap between the appearance of the
synovium upon imaging of unaffected children and active
JIA patients could be explained by too low a cut-off value
for pathologic synovial thickness (2.0 mm, as previously pro-
posed in JAMRIS) [5]. However, on the basis of the absolute
measures of synovial thickness per location for both readers,
no other (higher) appropriate cut-off value would lead to a
more distinct difference between unaffected children and ac-
tive JIA (data not shown).
To maximize the difference between a healthy condition
and pathology by means of the JAMRIS scoring method, we
decided to give more weight to the JIA-specific locations of
synovial thickening that we identified in the current study
which were completely absent in any of the controls. Our
study on the typical distribution of MRI abnormalities in JIA
already indicated a noticeable preference for synovial thick-
ening at the central locations in the knee [18]. Applying a
simple location-weighting as a simple revision of JAMRIS
by adding a point to the total score if synovial thickening
was solely present per infrapatellar and/or cruciate ligaments
location already proved to differentiate the unaffected children
from the active JIA patients. This now legitimizes further ex-
ploration of this location-weighting approach in larger JIA
study samples (Nusman et al., manuscript in preparation). A
semi-quantitative scoring method like the one developed for
MRI of the wrist in JIA patients may be an alternative
approach worth investigating because it may overcome
drawbacks of the measurement-based JAMRIS method
(e.g. variety in pathology boundary at different locations
or susceptibility to variation in the measurements due to
the small dimensions of the synovium and an in-plane res-
olution of 0.39 mm2) [27].
The procedure of standardized assessment of JIA patholo-
gy on MRI of the knee compared with unaffected children as
shown in the current study is analogous to the procedures in
the JIAwrist. After development of a (preliminary) MRI scor-
ing system for the wrist, data on the MRI appearance of the
wrist in healthy children led to redefining of the scoring sys-
tem for pathology [28–30]. Consequently, revised versions of
the original scoring system were developed and validated in
the wrist [27, 31, 32].
Our study has some limitations though. Besides the
autoinflammatory status and delay in timing of contrast in
our control cohort as discussed above, the discrepancy in field
strength of theMRI between the JIA group (1.0 T) and control
group (1.5 T) is another potential limitation. However, both
readers did not experience any problems with the MRI quality
nor were they able to identify JIA or unaffected children on
the basis of image quality differences. Also, the lack of fluid-
sensitive MRI sequences and other directions (due to time
restrictions in the unaffected children) hampers adequate in-
terpretation of synovial fluid and thickening.
In conclusion, mild enhancing synovial thickening can be
identified upon MRI of the knee in a cohort of children unaf-
fected by clinical arthritis. Infrapatellar and cruciate ligament
locations are unique sites affected by the inflammatory pro-
cess of JIAwhen compared to the data in our unaffected chil-
dren cohort. The existing JAMRIS system for the assessment
of synovial inflammation in JIA needs further refinement to
distinguish synovitis in JIA from enhancement in unaffected
children. The introduction of location-weighting to JAMRIS
to improve the score for synovial thickening needs further
development and validation in a larger JIA sample of patients
previously imaged and scored according to the non-revised
JAMRIS methodology.
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